Graphene Oxide-Silver Nanocomposite Enhances Cytotoxic and Apoptotic Potential of Salinomycin in Human Ovarian Cancer Stem Cells (OvCSCs): A Novel Approach for Cancer Therapy

International Journal of Molecular Sciences
Yun-Jung ChoiJin-Hoi Kim

Abstract

The use of graphene to target and eliminate cancer stem cells (CSCs) is an alternative approach to conventional chemotherapy. We show the biomolecule-mediated synthesis of reduced graphene oxide-silver nanoparticle nanocomposites (rGO-Ag) using R-phycoerythrin (RPE); the resulting RPE-rGO-Ag was evaluated in human ovarian cancer cells and ovarian cancer stem cells (OvCSCs). The synthesized RPE-rGO-Ag nanocomposite (referred to as rGO-Ag) was characterized using various analytical techniques. rGO-Ag showed significant toxicity towards both ovarian cancer cells and OvCSCs. After 3 weeks of incubating OvCSCs with rGO-Ag, the number of A2780 and ALDH⁺CD133⁺ colonies was significantly reduced. rGO-Ag was toxic to OvCSCs and reduced cell viability by mediating the generation of reactive oxygen species, leakage of lactate dehydrogenase, reduced mitochondrial membrane potential, and enhanced expression of apoptotic genes, leading to mitochondrial dysfunction and possibly triggering apoptosis. rGO-Ag showed significant cytotoxic potential towards highly tumorigenic ALDH⁺CD133⁺ cells. The combination of rGO-Ag and salinomycin induced 5-fold higher levels of apoptosis than each treatment alone. A combination of rGO-Ag and salinomycin at v...Continue Reading

References

Apr 3, 1992·Cell·G I EvanD C Hancock
Jan 1, 1990·Methods in Enzymology·A N Glazer, L Stryer
Jun 1, 1982·The Journal of Cell Biology·V T OiL Stryer
Jan 29, 2000·FEBS Letters·Y Tsujimoto, S Shimizu
Nov 7, 2000·The Journal of Biological Chemistry·G Q WangH Rabinowich
Nov 2, 2001·Nature·T ReyaI L Weissman
Jan 29, 2002·Toxicological Sciences : an Official Journal of the Society of Toxicology·María José Gómez-LechónRamiro Jover
Jun 5, 2004·Journal of Colloid and Interface Science·S Shiv ShankarMurali Sastry
Oct 23, 2004·Science·K S NovoselovA A Firsov
Sep 22, 2005·Cancer Chemotherapy and Pharmacology·Ryungsa KimKazuaki Tanabe
Dec 22, 2005·Development·Konstantinos MeletisJonas Frisén
Apr 15, 2006·Science·Claire BergerWalt A de Heer
Apr 22, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mark Branda, Jack R Wands
Jul 21, 2006·Nature·Sasha StankovichRodney S Ruoff
Dec 13, 2006·Physical Review Letters·A C FerrariA K Geim
Jul 27, 2007·Nature·Dmitriy A DikinRodney S Ruoff
Nov 1, 2007·BJU International·Jacques FerlayCarlo La Vecchia
Dec 25, 2007·Nano Letters·Konstantin N KudinRoberto Car
May 23, 2008·Cytokine & Growth Factor Reviews·Avi Ashkenazi
Jul 23, 2008·Molecular Cancer Research : MCR·Stephanie MaXin-Yuan Guan
Aug 7, 2008·Cell Stem Cell·Carla F Kim, Peter B Dirks
Oct 29, 2008·Oncogene·B Hoffman, D A Liebermann
Feb 25, 2009·ACS Nano·P V AshaRaniSuresh Valiyaveettil
Apr 1, 2009·Seminars in Oncology·Mario M Leitao, Dennis S Chi
Apr 8, 2009·Nature Nanotechnology·Sungjin Park, Rodney S Ruoff
Jul 8, 2009·Small·Renu PasrichaAvanish Kumar Srivastava
Sep 1, 2009·Colloids and Surfaces. B, Biointerfaces·Sangiliyandi GurunathanSoo Hyun Eom
May 15, 2010·Nature Reviews. Drug Discovery·Simone FuldaGuido Kroemer
Jul 28, 2010·Chemical Communications : Chem Comm·Zhigang XiongX S Zhao
Aug 25, 2010·ACS Nano·Daniela C MarcanoJames M Tour
Aug 27, 2010·Nano Letters·Sandip NiyogiRobert C Haddon
Sep 11, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Sten OrreniusBoris Zhivotovsky
Oct 12, 2010·ACS Nano·Omid Akhavan, Elham Ghaderi
Feb 3, 2011·Chemical Communications : Chem Comm·Young-Kwan KimDal-Hee Min
Apr 12, 2011·International Journal of Cancer. Journal International Du Cancer·Ilona KryczekWeiping Zou
Apr 27, 2011·International Journal of Cancer. Journal International Du Cancer·Xiao-Qun YeGui-Sheng Qian

❮ Previous
Next ❯

Citations

Sep 29, 2018·Cancers·Vivek KaushikAnand K V Iyer
Jul 22, 2019·International Journal of Molecular Sciences·Venkatesha NarayanaswamyBashar Issa
Feb 6, 2020·Mass Spectrometry Reviews·Na Li, Xianquan Zhan
Nov 21, 2018·Nanomaterials·Krzysztof TadyszakJagoda Litowczenko
Apr 11, 2019·Frontiers in Pharmacology·Petra JagustPatricia Sancho
Sep 20, 2020·International Journal of Molecular Sciences·Sangiliyandi GurunathanJin-Hoi Kim
Sep 15, 2020·International Journal of Nanomedicine·Claudia C BarreraDiana M Narváez
Oct 24, 2020·Drug Delivery and Translational Research·Jin CaoJayanth Panyam
Apr 4, 2021·International Journal of Molecular Sciences·Iruthayapandi Selestin RajaDong Wook Han
Jan 12, 2019·Nano-micro Letters·S Syama, P V Mohanan
Jul 31, 2021·The Science of the Total Environment·Ying MaTing Zhang
Aug 8, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nicola MicaleAntonio Speciale
Nov 28, 2021·International Journal of Molecular Sciences·Rafał KrętowskiMarzanna Cechowska-Pasko

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
scanning electron microscopy
xenografts
Fluorescence-Activated Cell Sorting

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.